학술논문
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
Document Type
Article
Author
Raghu, G.; Ghazipura, M.; Fleming, T.R.; Aronson, K.I.; Golinska, P.; Martinez, F.J.; Behr, J.; Brown, K.K.; Swigris, J.J.; Flaherty, K.R.; Kazerooni, E.A.; Maher, T.M.; Richeldi, L.; Lasky, J.A.; Busch, R.; Puthawala, K.; Seymour, S.; Karimi-Shah, B.; Garrard, L.; Ahn, D.-H.; Li, J.; Rodal, G.; Weir, N.; Danoff, S.K.; Ettinger, N.; Goldin, J.; Glassberg, M.K.; Kawano-Dourado, L.; Khalil, N.; Lancaster, L.; Lynch, D.A.; Mageto, Y.; Noth, I.; Shore, J.E.; Wijsenbeek, M.; Brown, R.; Grogan, D.; Ivey, D.
Source
In: American journal of respiratory and critical care medicine . (American journal of respiratory and critical care medicine, 15 March 2024, 209(6):647-669)
Subject
Language
English
ISSN
15354970